Lexicon Pharmaceuticals Inc (LXRX) — Cash Flow Reinvestment Rate
Lexicon Pharmaceuticals Inc (LXRX) has a Cash Flow Reinvestment Rate of 0.91x as of June 2025, reinvesting $15.48 Million (capex $0.00 plus investments $15.48 Million) from operating cash flow of $16.99 Million. See Lexicon Pharmaceuticals Inc (LXRX) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Lexicon Pharmaceuticals Inc Cash Flow Reinvestment Rate (2005–2019)
Historical reinvestment intensity for Lexicon Pharmaceuticals Inc across 3 annual periods. For the full cash flow conversion analysis, see Lexicon Pharmaceuticals Inc operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for Lexicon Pharmaceuticals Inc (2005–2019)
Year-by-year capital reinvestment analysis for Lexicon Pharmaceuticals Inc. See LXRX financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 1.37x | $155.85 Million | $113.81 Million | $70.00K | ▲ +115.6% |
| 2015 | 0.64x | $117.36 Million | $184.78 Million | $910.00K | ▲ +32.0% |
| 2005 | 0.48x | $11.28 Million | $23.44 Million | $11.28 Million | — |